159 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
and CKD EMPA-REG OUTCOME ... T2DM; first renal outcomes ... Dapagliflozin improved HF outcomes ... inhibitors #EBM #trial #visualabstract ... #table #CVD #CKD
The AIRWAYS-2 Randomized Clinical Trial Infographic - A Visual Abstract

Effect of a Strategy of a Supraglottic
Tracheal Intubation During ... on Functional Outcome ... 2698493 #EBM #VisualAbstract
Outcomes in Severe Hyponatremia Treated With and Without Desmopressin.

Am J Med. 2018 Mar;131(3):317.e1-317.e10. doi: 10.1016/j.amjmed.2017.09.048. Epub
Outcomes in Severe ... #Hyponatremia #Outcomes ... #amjmed #VisualAbstract
FDA-Approved 1st line Medications for Tobacco Cessation Treatment

Nicotine patch, Nicotine lozenge, Nicotine gum, Nicotine inhaler, Nicotine
, Varenicline (tablet ... release (SR) (tablet ... Therapy #Comparison #Table ... #Agents #Dosing
POLAR Randomized Clinical Trial - Effect of Early Sustained Prophylactic Hypothermia on Neurologic Outcomes Among Patients
on Neurologic Outcomes ... improve neurologic outcomes ... CriticalCare #ICU #VisualAbstract
#VisualAbstract for #Lancet trial #CANVASR #SGLT2i #Canagliflozin

"Canagliflozin and renal outcomes in type 2 diabetes: results from
#VisualAbstract ... Canagliflozin and renal outcomes
Summary of dosing recommendations in renal impairment of commonly used hypoglycaemic agents

#Diabetes #Diabetic #Medications #Pharmacology #Dosing
Summary of dosing ... #Pharmacology #Dosing ... #Dosing #Renal ... Impairment #CKD #Table
Transdermal Fentanyl require unique dosing conversions. For Adult and pediatric patients taking opiouds or doses not
require unique dosing ... not listed in Table ... morphine dose using ... Table A 3. ... Then using Table
Medicare versus VA Visual Abstract Sarah Gleeson @sarah_gleeson_
Dialysis Initiation and Mortality Among Older Veterans With Kidney
#Hemodialysis #Outcomes ... VeteransAffairs #VisualAbstract
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Medications Summary Table ... events, Improved outcomes ... #medications #table